Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech has submitted a routine compliance certificate to BSE under SEBI's Regulation 74(5) for the quarter ended 31 December 2025. The certificate was issued by the company's Registrar and Transfer Agent (RTA), Beetal Financial & Computer Services, dated 5 January 2026. The RTA confirms that all securities received from Depository Participants for demat conversion during the quarter were properly accepted/rejected and reported back to the depositories. It also confirms that physical certificates received for dematerialization were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's register of members within the 15-day deadline.
This is a standard procedural filing with no impact on the company's financials, operations, or stock price. It merely certifies that the RTA is handling demat requests correctly — no action is needed from shareholders.